The expression of the large amino acid transporter.
The brain depends upon a supply of various nutrients for maintenance of physiologic function and metabolic homeostasis. Although not a major source of metabolic energy, amino acids are critically important for essential metabolic pathways and for performing specialized func tions. Amino acids serve as integral units in the synthesis of all central nervous system (CNS) proteins during brain maturation and steady-state turnover of CNS proteins. Some amino acids (glutamate, aspartate, glycine, and others) serve as chemical messengers for cell-cell com munication, and others (tyrosine, glutamine, tryptophan, histidine, and arginine) are precursors of major CNS neu rotransmitters (dopamine, norepinephrine, GABA. sero tonin, histamine. nitric oxide) (Cooper et al.. 1996) . At least two amino acids (glutamate. glutamine) are known to play a significant role in eliminating excess ammo nium ion from brain and in maintaining osmotic equilib rium between neuronal and glial cells and their environ ment (Lee et al.. 1998) . Although neural cells are capable as in heart and testis, whereas the protein was absent or only faintly detectable in muscle, kidney, and liver. In brain sec tions, the antibody intensely labeled the luminal and abluminal membranes of brain microvessel endothelial cells in all brain areas examined including cerebral cortex, cerebellum, hippo campus, and in gray and white matter regions. These results suggest that LATI is involved in transcellular transport and may play an important role in large, neutral amino acid transfer across the blood-brain barrier. Key Words: Blood-brain bar rier-Amino acid transporter-Endothelium-Immunocyto chemistry-Transport-mRNA.
of amino acid biosynthesis, many amino acids. including the essential ones, are delivered to the brain through the circulating plasma.
A hallmark characteristic of the brain vasculature is an endothelium with tight occluding junctions at positions of cell-cell contact resulting in the so-called blood-brain barrier (Brightman and Reese, 1969) . For transcellular transport of amino acids across the brain vasculature to occur, transport systems must be located in the luminal and abluminal plasma membranes of the vascular endo thelial cells (Pardridge, 1983) . In vivo and in vitro ap proaches have been used to determine the functional characteristics of blood-brain amino acid transport, and several sodium-dependent and sodium-independent sys tems have been detected. A system with a relatively high transport capacity was identified and exhibited the char acteristics of System L, the sodium independent trans porter for large. neutral amino acids (Oldendorf. 1971 ) .
Recent advances by application of molecular techniques have led to the isolation. cloning, and identification of two closely related System L amino acid transporter mRNA, LAT I and LAT2 (Kanai et a!., 1998; Pineda et aI., 1999; Segawa et aI., 1999) . Although evidence has been presented that the mRNA transcript for LA T I is present in brain (Kanai et aI., 1998) , and more precisely at the blood-brain barrier (Boado et a!., 1999) . the exact cellular location of this transport protein has not yet been reported. In the current study, an affinity-purified antibody, raised in chicken against rat LAT 1, was used to localize this transporter in the brain by the use of immu noblotting and immunocytochemistry techniques. The authors report that LAT I protein is abundantly expressed by rat brain capillary endothelial cells and is located at the luminal and abluminal membranes, thus suggesting that LAT 1 is the primary carrier of large, neutral amino acids across the blood-brain barrier. Thus, transcellular transport of amino acids through the brain vascular en dothelium by LA T 1 is an important process in overall brain metabolism and integral to normal brain function. Demonstration of LA T 1 transcript and protein in rat brain endothelium and other brain structures now enables experimental approaches for investigating alterations of this transporter under pathologic conditions.
MATERIALS AND METHODS
All procedures using animals followed a protocol approved by the University of Minnesota Animal Care Committee.
eDNA, reverse transcription, and polymerase chain reaction procedures
Polymerase chain reaction analysis was used to detect the presence of LATI transcripts in whole rat brain, choroid plexus, and cerebral microvessels. For whole brain, total RNA was extracted from fresh tissue (Qiagen, Valencia, CA, U.S.A.) and used to prepare cDNA according to the manufacturer's instructions (cDNA Cycle Kit; Invitrogen, San Diego, CA, U.S.A.). Rat brain microvessel and choroid plexus cDNA li braries were obtained by isolating brain microvessels (Gerhart et aI ., 1988) and choroid plexuses and subsequently extracting poly(A)+ RNA (Invitrogen). The respective libraries were con structed commercially (Invitrogen) according to the modified procedure of Gubler and Hoffman (1983) 
RESULTS

Transcript analysis by polymerase chain reaction
Transcript for the amino acid transporter LA T 1 was readily detected in cDNA libraries constructed from rat brain microvessels and choroid plexus and in whole rat brain RNA extracts (Fig. lA) . A long (1 691 bp) and two short (182 bp, 192 bp) amplicons were produced by PCR using LA T I specific primers. The sizes of the products corresponded to the predicted sizes based on the primer pairs. The identity of each was verified by isolation of the products from the gels and sequencing. Because the primers for the 182 bp product are also capable of hy bridizing to cDNA from TAl , a truncated form of LA Tl that was previously reported (Sang et aI., 1995) , this product may have been amplified from either LA T I or TA1 .
Immunoblot analysis of LA Tl
The N-terminal LA Tl antibody recognized a protein migrating with an apparent molecular mass of -45 kDa on immunoblots of brain membranes from cerebral cor tex and cerebellum of adult rats (Fig. 1 B) . This protein was not observed when the antibody was preabsorbed with any of the tested concentrations of LAT 1 peptide. A similar protein was observed in immunoblots of mem brane preparations from all CNS regions investigated that is, the frontoparietal cortex, hippocampus, hypo thalamus, cerebellum, brainstem, and spinal cord. LAT I was also detected in heart and testis, but was absent or only faintly detected in kidney, liver, and muscle (data not shown).
The antibody raised against the C-terminal end of LATI was expected to detect the C-terminal of LATl and the C-terminal of TAl, the approximately 28 kDa truncated form of LA Tl (Sang et aI., 1995) . However, the C-terminal peptide was an unsatisfactory antigen, and this antibody was not further evaluated.
Immunocytochemistry
Using the N-terminal LATl antibody, the most intense LA T I staining in sections of cerebral cortex was found in brain capillary endothelium where it appeared to stain all microvessels (Fig. 2) . The staining was relatively uni formly distributed within the capillaries and examination under high magnification suggested that LA T 1 was lo cated in the luminal and abluminal membranes of capil lary endothelium ( Fig. 2B and 2C) . Capillaries were similarly stained in sections of rat cerebellum, including those in the molecular layer, granular layer, and in the cerebellar white matter (Fig. 2D ). Microvessels in hip pocampus and other brain regions were also stained. LA T I was also detected in the microvascular endothe lium of rat pup brain (data not shown).
In contrast to the vascular endothelium, immunostain ing of LATl in the neuropil was weak ( Fig. 2A) . How ever, the staining in the neuropil disappeared when the antibody was preabsorbed with peptide.
DISCUSSION
To transport amino acids across their plasma mem branes, cells are equipped with integral membrane pro teins that function to recognize, bind, and translocate specific amino acids from one side of the membrane to the other. These amino acid transporters belong to a large and from rat brain microvessel (MV) and choroid plexus (CP) cDNA librar ies were used as templates. LAT1 specific products were predicted and detected at 182 bp (lanes 1,4, and 7) , 6, and 9 ). The standard molecular weight DNA ladder is also shown (lane 10). Note that the trun cated version of LAT1, called T A 1 , also encodes the 182 bp template and may produce this product. (0) Rat brain cerebellum. Note that microvessels are stained with LAT1 in all layers-the molecular layer (M), the granular layer (G), and in the cerebellar white matter (W). (E) Peptide control of rat brain cortex. No specific staining could be detected when the LAT1 antibody was preincubated with 20 IJg/mL of peptide. Horizontal bar = 60 IJm (A), 6.7 IJm (8), 25 IJm (C), and 75 IJm (0 and E).
superfamily of amino acid/polyamine/choline (APC) transporters (Verrey et aI., 1999) , of which approxi mately 300 members have been sequenced. As with other transport proteins (for example, the glucose transporters (Mueckler et al., 1985) or the monocarboxylate trans porters (Halestrap and Price, 1999) ), the amino acid transporters that have been characterized at the molecu lar level exhibit a topology consisting of 12 membrane spanning segments with both ends of the protein termi nating in the cytoplasm. The large amino acid (LAT) transporter family was identified as a subgroup of the APC transporter superfamily. These transporters are re sponsible for the exchange of neutral, cationic, or anionic amino acids. One member of the System L family, LA Tl, was the subject of the present investigation. These studies demonstrate the development and appli cation of tools for detection of the LA T I transcript and protein in the rat. Thus, future studies using in situ, in vitro, and in vivo assays to investigate alterations in LATl expression in this experimental animal during develop ment and under pathologic conditions will be possible.
LATl mRNA was found in brain microvessels, a preparation enriched in cells of the vascular endothelium and constituting the blood-brain barrier. Boado et al. (1999) likewise found an approximately 100-fold greater transcript expression in bovine brain microvessels than in whole brain extracts. In addition to detecting LAT I mRNA in microvessels and whole brain, the current study also reports the transcript in the choroid plexus, the location of the blood-cerebral spinal fluid barrier.
The current study reports that not only is the mRNA for the amino acid transporter LATI present in brain, but also that the LATI protein is abundantly expressed in the luminal and abluminal membranes of capillary endothe lial cells of all brain regions examined. Transport of blood-borne amino acids into brain is important for maintaining metabolic homeostasis and normal function ing of the brain. Blood-brain transport of amino acids was first characterized by Oldendorf using the brain up take index method (Oldendorf, 1971 ) . Subsequent stud ies reported that this transport was saturable, stereospe cific, sodium-independent and that it exhibited specific ity for large, neutral amino acids such as phenylalanine, tyrosine, tryptophan, leucine, isoleucine, and valine (01dendorf and Szabo, 1976; Smith, 1991 ; Smith et aI., 1987) . Although these in vivo studies of rat brain con cluded that System L transporters were located on the luminal side of the endothelial cell, in vitro studies using freshly isolated microvessels also demonstrated System L on the abluminal side (Betz and Goldstein, 1978; Au dus and Borchardt, 1986; Choi and Pardridge, 1986; del Pino et aI., 1995) . These properties and observations are consistent with the characteristics of LA T 1 and the im munocytochemical localization reported here.
The pattern of membrane localization for LAT I in luminal and abluminal endothelial membranes is similar to that for glucose and monocarboxylic acid transport systems that function in transcellular transport of their respective brain nutrients (Gerhart et aI., 1989; Pardridge et aI., 1990; Lee et aI., 1997; Gerhart et aI., 1998) . Trans port studies in other species, including humans and dogs (Betz et aI., 1975; Oldendorf, 1977) , suggest that the presence of System L transporters on luminal and ablu minal membranes of the brain microvasculature is likely to be broadly conserved among species. More recent and detailed studies of brain endothelium (Smith and Stoll, 1998) have demonstrated the presence of at least seven additional amino acid transport systems, each with dis tinct specificities, including some that require sodium for cotransport and some with asymmetric distribution in the endothelial cell membranes.
The functional properties of the LAT1 protein have been described by Kanai et al. (1 998) . The transport of amino acids by LA T I is sodi um-independent, and the preferential substrates are neutral amino acids with branched or aromatic side chains. To be functional, LATI requires association with the membrane glycopro tein known as 4F2hc (Broer et aI., 1997; Kanai et aI., 1998) . 4F2hc forms a heterodimer complex with LATI and is involved in the control of intracellular trafficking of the complex, although the nature of the interaction remains unclear. Other homologues of LAT I may also form heterodimers with the membrane gloycoprotein 4F2hc. Mastroberardino et al. (1 998) hypothesized that the heavy chain of 4F2hc is linked by an extracellular disulfide bond to LA T 1 and that its single transmem brane segment is located near the second and third trans membrane domains of LA T. Previous reports indicate that LAT I activity is regulated by hormones or bioactive molecules (Smith, 1991) such as arginine-vasopressin and f3-adrenergic agents (Brust, 1986; Eriksson and Carlsson, 1988) . Whether associated proteins such as 4F2hc are involved in this modulation of transport ac tivity remains to be determined.
Little is currently known about the regulation of LA Tl expression. Based on the current results and other stud ies, it seems likely that brain endothelial cells express high levels of LA Tl for transcellular transport of amino acids rather than for supplying amino acids for their own consumption. Therefore, the high constitutive expression of LA T I by endothelial cells may be influenced by fac tors in the environment of these cells. For example, in duction of LA T 1 expression may result from the influ ence of the surrounding astrocytes much like has been suggested for other proteins characteristic of the brain endothelial cell. In addition, pathologic conditions such as hepatic encephalopathy or the amino acidurias may involve altered expression of blood-brain amino acid transporters such as LATI (Pardridge, 1998) . With the newly available probes for LATI mRNA and protein, molecular analysis of these mechanisms will be possible in future studies.
